Astera Labs (NASDAQ:ALAB) Announces Quarterly Earnings Results

Astera Labs (NASDAQ:ALABGet Free Report) released its earnings results on Tuesday. The company reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.39 by ($0.13), Zacks reports. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. Astera Labs updated its Q4 2025 guidance to 0.50-0.510 EPS.

Astera Labs Stock Down 6.4%

ALAB traded down $12.25 on Tuesday, reaching $179.31. The company’s stock had a trading volume of 8,765,759 shares, compared to its average volume of 5,234,111. The stock has a 50 day moving average of $196.78 and a two-hundred day moving average of $137.86. The company has a market capitalization of $29.80 billion, a price-to-earnings ratio of 320.20, a P/E/G ratio of 4.66 and a beta of 1.38. Astera Labs has a fifty-two week low of $47.13 and a fifty-two week high of $262.90.

Insider Transactions at Astera Labs

In related news, CEO Jitendra Mohan sold 152,517 shares of the company’s stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $170.33, for a total value of $25,978,220.61. Following the completion of the transaction, the chief executive officer directly owned 450,001 shares of the company’s stock, valued at $76,648,670.33. This represents a 25.31% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Stefan A. Dyckerhoff sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $173.42, for a total value of $4,335,500.00. Following the completion of the transaction, the director directly owned 99,154 shares of the company’s stock, valued at $17,195,286.68. This trade represents a 20.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,092,997 shares of company stock valued at $192,231,120 over the last three months. 12.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. State Street Corp boosted its holdings in Astera Labs by 39.3% in the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock valued at $193,812,000 after purchasing an additional 604,363 shares in the last quarter. Holocene Advisors LP acquired a new position in Astera Labs in the second quarter valued at approximately $55,827,000. Adage Capital Partners GP L.L.C. lifted its stake in Astera Labs by 27.2% in the second quarter. Adage Capital Partners GP L.L.C. now owns 589,932 shares of the company’s stock valued at $53,342,000 after buying an additional 126,000 shares during the last quarter. Public Sector Pension Investment Board lifted its stake in Astera Labs by 196.0% in the second quarter. Public Sector Pension Investment Board now owns 296,000 shares of the company’s stock valued at $26,764,000 after buying an additional 196,000 shares during the last quarter. Finally, Raymond James Financial Inc. lifted its stake in Astera Labs by 401.0% in the second quarter. Raymond James Financial Inc. now owns 215,909 shares of the company’s stock valued at $19,522,000 after buying an additional 172,814 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ALAB has been the subject of several research reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astera Labs in a research report on Wednesday, October 8th. Wall Street Zen raised Astera Labs from a “hold” rating to a “buy” rating in a research report on Monday. Morgan Stanley boosted their price objective on Astera Labs from $155.00 to $200.00 and gave the stock an “overweight” rating in a research report on Friday, August 29th. CICC Research started coverage on Astera Labs in a research report on Friday, August 29th. They set an “outperform” rating and a $190.00 price objective for the company. Finally, Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price objective for the company. in a research report on Tuesday, July 22nd. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $162.06.

Check Out Our Latest Report on Astera Labs

About Astera Labs

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Recommended Stories

Earnings History for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.